[APLS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -7.10%
YoY- -27.96%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 146,377 99,182 94,969 44,846 22,663 22,056 16,322 329.92%
PBT -87,153 -140,004 -121,843 -177,496 -167,462 -190,823 -155,491 -31.94%
Tax 1,423 233 194 282 -1,471 446 486 104.26%
NP -88,576 -140,237 -122,037 -177,778 -165,991 -191,269 -155,977 -31.35%
Tax Rate - - - - - - - -
Total Cost 234,953 239,419 217,006 222,624 188,654 213,325 172,299 22.90%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -60.51 -141.39 -128.50 -396.42 -732.43 -867.20 -955.62 -84.03%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.73 -1.17 -1.02 -1.56 -1.50 -1.75 -1.46 -36.92%
EPS Diluted -0.73 -1.17 -1.02 -1.56 -1.50 -1.75 -1.46 -36.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.